-
Urine high‐risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-25 Jennifer C. Davies, Alexandra Sargent, Elisabeth Pinggera, Suzanne Carter, Clare Gilham, Peter Sasieni, Emma J. Crosbie
ObjectiveTo evaluate the sensitivity of human papillomavirus (HPV) tested urine to detect high‐grade cervical precancer (cervical intraepithelial neoplasia grade 2+ [CIN2+]) using two urine collection devices.DesignRandomised controlled trial.SettingSt Mary's Hospital, Manchester, UK.PopulationColposcopy attendees with abnormal cervical screening; a total of 480 participants were randomised. Matched
-
Treatment methods for cervical intraepithelial neoplasia in England: A cost‐effectiveness analysis BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-25 Michela Tinelli, Antonios Athanasiou, Areti Angeliki Veroniki, Orestis Efthimiou, Ilkka Kalliala, Sarah Bowden, Maria Paraskevaidi, Deirdre Lyons, Pierre Martin‐Hirsch, Phillip Bennett, Evangelos Paraskevaidis, Georgia Salanti, Maria Kyrgiou, Huseyin Naci
ObjectiveTo compare the cost‐effectiveness of different treatments for cervical intraepithelial neoplasia (CIN).DesignA cost‐effectiveness analysis based on data available in the literature and expert opinion.SettingEngland.PopulationWomen treated for CIN.MethodsWe developed a decision‐analytic model to simulate the clinical course of 1000 women who received local treatment for CIN and were followed
-
Planned oocyte cryopreservation: a systematic review and meta-regression analysis Hum. Reprod. Update (IF 13.3) Pub Date : 2024-04-24 Ayala Hirsch, Bruria Hirsh Raccah, Reut Rotem, Jordana H Hyman, Ido Ben-Ami, Avi Tsafrir
BACKGROUND Awareness of the age-related decline in fertility potential has increased the popularity of planned oocyte cryopreservation (POC). However, data regarding outcomes of POC, including rates of women returning to thaw oocytes, as well as pregnancy and live birth rates, are scarce and based mostly on small case series. OBJECTIVE AND RATIONALE POC was defined as cryopreservation exclusively for
-
Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3) Hum. Reprod. (IF 6.1) Pub Date : 2024-04-22 Jacques Donnez, Christian Becker, Hugh Taylor, Francisco Carmona Herrera, Olivier Donnez, Andrew Horne, Maciej Paszkowski, Felice Petraglia, Stefan P Renner, Amisha Patel, Mitra Boolell, Elke Bestel, Marie-Madeleine Dolmans
STUDY QUESTION Does linzagolix administered orally once daily for up to 3 months at a dose of 75 mg alone or 200 mg in combination with add-back therapy (ABT) (1.0 mg estradiol; 0.5 mg norethindrone acetate, also known as norethisterone acetate [NETA]) demonstrate better efficacy than placebo in the management of endometriosis-related dysmenorrhea and non-menstrual pelvic pain? SUMMARY ANSWER Combining
-
The long‐term impact of vaginal surgical mesh devices on pain clinic and psychological service referrals, anti‐inflammatory testing and pelvic scans in UK primary care: A cohort study with the Clinical Practice Research Datalink BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-22 Emily McFadden, Carl Heneghan
ObjectiveTo examine long‐term complications in women with stress urinary incontinence (SUI) and pelvic organ prolapse (POP), with and without surgical mesh implants.DesignLongitudinal open cohort study from 1 April 2006 (or 1 April 2012) to 30 November 2018.SettingThe Clinical Practice Research Datalink (CPRD) Gold database, which is linked to Hospital Episodes Statistics (HES) inpatient data, the
-
Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-17 Kimberly K Vesco, Anna E Denoble, Heather S Lipkind, Elyse O Kharbanda, Malini B DeSilva, Matthew F Daley, Darios Getahun, Ousseny Zerbo, Allison L Naleway, Lisa Jackson, Joshua T B Williams, Thomas G Boyce, Candace C Fuller, Eric S Weintraub, Gabriela Vazquez-Benitez
To evaluate the association between antenatal messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination and risk of adverse pregnancy outcomes.
-
Syphilis Treatment Among People Who Are Pregnant in Six U.S. States, 2018-2021. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-17 Ayzsa Tannis, Kathryn Miele, Jeffrey M Carlson, Kevin P O'Callaghan, Kate R Woodworth, Breanne Anderson, Aisha Praag, Kourtney Pulliam, Nicole Coppola, Teri' Willabus, Deborah Mbotha, Dejene Abetew, Salvatore Currenti, Nicole D Longcore, Amanda Akosa, Dana Meaney-Delman, Van T Tong, Suzanne M Gilboa, Emily O Olsen
To describe syphilis treatment status and prenatal care among people with syphilis during pregnancy to identify missed opportunities for preventing congenital syphilis.
-
Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-16 Umair Masood, Nicholas Venturini, Paola Nicoletti, Andrew Dellinger, David Kleiner, Herbert L Bonkovsky, Huiman Barnhart, Raj Vuppalanchi, Simona Rossi, Joseph A Odin, Tatyana Kushner
There are limited data on the causative agents and characteristics of drug-induced liver injury in pregnant individuals. Data from patients with drug-induced liver injury enrolled in the ongoing multicenter Drug-Induced Liver Injury Network between 2004 and 2022 and occurring during pregnancy or 6 months postpartum were reviewed and compared with cases of drug-induced liver injury in nonpregnant women
-
Neurologic Emergencies in Pregnancy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-16 Shaun R Wesley, G Edward Vates, Loralei L Thornburg
Neurologic emergencies in pregnancy require prompt evaluation and early, focused intervention to improve neurologic outcomes for the affected person and to avoid further injury. Neurologic events in pregnancy, although rare, present a time of extreme risk of permanent injury for the person who is pregnant. Therefore, obstetric clinicians should be well versed in the risk factors for potential neurologic
-
National Postpartum Permanent Contraception Practices and Perceived Barriers. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-16 Ellen Murphy, Andrea Pelletier, Kathryn Fay, Deborah Bartz
Single institution-level studies have demonstrated low postpartum permanent contraception fulfillment rates after vaginal birth. To explore the national scope of the problem, we collected cross-sectional survey data from faculty at 109 U.S. academic medical centers to elicit perceptions about postpartum permanent contraception practices after vaginal birth, including barriers to and changes in practice
-
Pathophysiology and Clinical Implications of Ovarian Endometriomas. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-16 Farr R Nezhat, Ann M Cathcart, Ceana H Nezhat, Camran R Nezhat
Ovarian endometriomas affect many patients with endometriosis and have significant effects on quality of life, fertility, and risk of malignancy. Endometriomas range from small (1-3 cm), densely fibrotic cysts to large (20 cm or greater) cysts with varying degrees of fibrosis. Endometriomas are hypothesized to form from endometriotic invasion or metaplasia of functional cysts or alternatively from
-
Obstetric anal sphincter injury in the second birth after perineal wound complication in the first birth: A nationwide register cohort study BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-16 Agnes Rygaard, Maria Jonsson, Anna-Karin Wikström, Sophia Brismar-Wendel, Susanne Hesselman
To investigate whether perineal wound complications in the first birth, alone or in conjunction with obstetric anal sphincter injury (OASI), is associated with an increased risk of OASI in the second birth.
-
Body image and pelvic floor dysfunction in pregnancy and postpartum: A prospective one-year follow-up cohort study BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-16 Laura Cattani, Dominique Van Schoubroeck, Christine De Bruyn, Sophie Ghesquière, Jan Deprest
To determine the prevalence of pelvic floor dysfunction (PFD) among pregnant women, their clustering and their association with body image disturbance (BID) up to 1 year postpartum.
-
Determinants of obstructed labour and associated outcomes in 54 referral hospitals in Nigeria BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-15 Samuel Adelaiye, Ishaya Wanonyi, Abiodun Adanikin, Abdulkarim Mairiga, Abubakar Kadas, Joel Morrupa, Tina Lavin, Abubakar Lamara, Ibrahim Yahaya, Jamilu Tukur, Calvin Chama
ObjectiveTo estimate the prevalence of obstructed labour, associated risk factors and outcomes across a network of referral hospitals in Nigeria.DesignRetrospective observational study.SettingA total of 54 referral‐level hospitals across the six geopolitical regions of Nigeria.PopulationPregnant women who were diagnosed with obstructed labour during childbirth and subsequently underwent an emergency
-
Gut bacteriome and mood disorders in women with PCOS Hum. Reprod. (IF 6.1) Pub Date : 2024-04-14 S Lee, M V Tejesvi, E Hurskainen, O Aasmets, J Plaza-Díaz, S Franks, L Morin-Papunen, J S Tapanainen, T S Ruuska, S Altmäe, E Org, A Salumets, R K Arffman, T T Piltonen
STUDY QUESTION How does the gut bacteriome differ based on mood disorders (MDs) in women with polycystic ovary syndrome (PCOS), and how can the gut bacteriome contribute to the associations between these two conditions? SUMMARY ANSWER Women with PCOS who also have MDs exhibited a distinct gut bacteriome with reduced alpha diversity and a significantly lower abundance of Butyricicoccus compared to women
-
“Walking on eggshells”: will PIEZO-intracytoplasmic sperm injection emerge as a new standard for penetrating the PIEZona pellucida? Fertil. Steril. (IF 6.7) Pub Date : 2024-04-13 Lawrence Engmann M.D., Stephanie Hallisey M.D., Alison Bartolucci Ph.D.
-
Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-11 Timothy Wen, Loralei L Thornburg, Mary E Norton, Lawrence D Platt, Lorraine Dugoff, Ashley Hesson, Jean L Spitz, Gregory Toland, Bryann Bromley
Nuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall
-
Prophylactic ureteric catheterisation during complex gynaecological surgery: A systematic review and meta‐analysis BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-11 Mahalakshmi Gurumurthy, Alice E. McGee, Lucky Saraswat
BackgroundThere is a lack of robust evidence to recommend the use of perioperative ureteric catheterisation or stenting in complex gynaecological surgery.ObjectivesTo evaluate the evidence on the benefits and risks of perioperative ureteric catheterisation or stenting in complex gynaecological surgery.Search strategyA literature search was performed in CINAHL, the Cochrane Library, Embase and MEDLINE
-
Prevalence, perinatal outcomes and factors associated with neonatal sepsis in Nigeria BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-11 Chinyere Ukamaka Onubogu, Uchenna Ekwochi, Ijeoma Obumneme‐Anyim, Linda Nneka Nwokeji‐Onwe, George Uchenna Eleje, Nnabuike Okechukwu Ojiegbe, Ifeanyichukwu Uzoma Ezebialu, Eziamaka Pauline Ezenkwele, Emily Akuabia Nzeribe, Uchenna Anthony Umeh, Innocent Anayochukwu Ugwu, Ogochukwu Chianakwana, Nkechi Theresa Ibekwe, Onyebuchi Ignatius Ezeaku, Gloria Nwuka Ekweagu, Abraham Bong Onwe, Tina Lavin, Bose
ObjectiveTo examine the prevalence, perinatal outcomes and factors associated with neonatal sepsis in referral‐level facilities across Nigeria.DesignSecondary analysis of data from the Maternal and Perinatal Database for Quality, Equity and Dignity Programme in 54 referral‐level hospitals across Nigeria.SettingRecords covering the period from 1 September 2019 to 31 August 2020.PopulationMothers admitted
-
Improving vitrification efficiency of human in vitro matured oocytes by the addition of LEA proteins Hum. Reprod. (IF 6.1) Pub Date : 2024-04-09 Lu Li, Xingyu Bi, Xueqing Wu, Zhongrong Chen, Yunxia Cao, Gang Zhao
STUDY QUESTION Can the addition of late embryogenesis-abundant (LEA) proteins as a cryoprotective agent during the vitrification cryopreservation of in vitro matured oocytes enhance their developmental potential after fertilization? SUMMARY ANSWER LEA proteins improve the developmental potential of human in vitro matured oocytes following cryopreservation, mostly by downregulating FOS genes, reducing
-
Using the theory of planned behavior to predict parents’ disclosure of donor conception to their children: a longitudinal study Hum. Reprod. (IF 6.1) Pub Date : 2024-04-09 Johan Paulin, Kimmo Sorjonen, Gunilla Sydsjö, Claudia Lampic
STUDY QUESTION Can the application of the theory of planned behavior (TPB) help predict heterosexual parents’ disclosure of donor conception to their children? SUMMARY ANSWER Parents with a stronger will to act in accordance with social norms favoring disclosure were more likely to start the disclosure process within the next 5–9 years. WHAT IS KNOWN ALREADY In contrast to single mothers by choice
-
Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-08 Anne Knisely MD, Maria D. Iniesta MD PhD, Claire A. Marten PharmD, Gary Chisholm MS, Kathleen M. Schmeler MD, Jolyn S. Taylor MD
Surgical site infection is one of the most common complications of gynecologic cancer surgery. Current guidelines recommend the administration of cefazolin preoperatively to reduce surgical site infection rates for patients undergoing clean-contaminated surgeries such as hysterectomy. To evaluate the impact of a quality improvement project adding metronidazole to cefazolin for antibiotic prophylaxis
-
Establishment of Maternal and Perinatal Database for Quality, Equity and Dignity (MPD‐4‐QED) programme: Processes, challenges, lessons and prospects BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-08 Abiodun Adanikin, Jamilu Tukur, Tina Lavin, Bosede Ezekwe, Is'haq Aminu, Peter Aboyeji, Olubukola Adesina, Calvin Chama, Saturday Etuk, Hadiza Galadanci, Joseph Ikechebelu, Olufemi T. Oladapo
1 INTRODUCTION Many low- and middle-income countries (LMICs) with high maternal mortality rates lack reliable routinely collected data on the quality of care provided to women giving birth in facilities nationwide and information when a death occurs. Although global efforts have been made to address the high numbers of maternal and perinatal deaths (e.g. by increasing the number of women who access
-
Outcomes and quality of care for women and their babies after caesarean section in Nigeria BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-04 Abiodun S. Adeniran, Duum C. Nwachukwu, Amaka N. Ocheke, Salisu O Mohammed, Abdulkarim O. Musa, Silas Ochejele, Rais S. Ibraheem, Samuel Pam, Amsa B. Mairami, Aishatu A. Gobir, Eyinade K. Olateju, Fatimah J. Baba, Patricia F. Medupin, Grace Ahmed, Sarah Ango, Godwin Akaba, Taofik O. Ogunkunle, Egwu Agada, Luz Gibbons, Olufemi T. Oladapo, Tina Lavin, Jamilu Tukur, Abiodun P. Aboyeji
To describe the outcomes and quality of care for women and their babies after caesarean section (CS) in Nigerian referral-level hospitals.
-
Equivalence of single and standard doses of antenatal corticosteroids for late preterm neonatal outcomes: insights from a secondary analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-07 Yossi Bart MD, Suneet P. Chauhan MD HonDSc, Michal Fishel Bartal MD, Sean Blackwell MD, Baha M. Sibai MD
The recent paradigm shift of treating individuals at risk of late preterm birth with antenatal corticosteroids warrants an assessment of the effect of single dosage. To compare outcomes of neonates born in the late preterm period (34.0–36.6 weeks) after a single dose of antenatal corticosteroids vs placebo. We performed a secondary analysis of the Antenatal Late Preterm Steroids trial. All individuals
-
Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19): Autoimmune Follicle-Stimulating Hormone (FSH) and FSH Receptor Blockade. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-05 Rachel Stern, Moses Bibi, Martin D Keltz
Since the onset of the coronavirus disease (COVID-19) pandemic, a variety of long-COVID-19 symptoms and autoimmune complications have been recognized.
-
Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2-7 Years After Delivery. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-05 Kartik K Venkatesh, Sadiya S Khan, Lynn M Yee, Jiqiang Wu, Rebecca McNeil, Philip Greenland, Judith H Chung, Lisa D Levine, Hyagriv N Simhan, Janet Catov, Christina Scifres, Uma M Reddy, Victoria L Pemberton, George Saade, C Noel Bairey Merz, William A Grobman
To determine whether adverse pregnancy outcomes are associated with a higher predicted 30-year risk of atherosclerotic cardiovascular disease (CVD; ie, coronary artery disease or stroke).
-
Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-05 Alexa Kanbergs, Kirsten Jorgensen, Nuria Agusti, David Viveros-Carreño, Chi-Fang Wu, Roni Nitecki, John A Harris, Terri Woodard, Ryan Ramphul, Jose Alejandro Rauh-Hain
To assess the effect of geographic factors on fertility-sparing treatment or assisted reproductive technology (ART) utilization among women with gynecologic or breast cancers.
-
Association Between Hypertensive Disorders of Pregnancy and Interval Neurocognitive Decline: An Analysis of the Hispanic Community Health Study/Study of Latinos. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-05 Tali Elfassy, Shathiyah Kulandavelu, Leah Dodds, Robert A Mesa, Tatjana Rundek, Vera Sharashidze, Michael Paidas, Martha L Daviglus, Michelle A Kominiarek, Ariana M Stickel, Krista M Perreira, Marissa A Kobayashi, Tanya P Garcia, Carmen R Isasi, Richard B Lipton, Hector M González
To evaluate whether hypertensive disorders of pregnancy, including gestational hypertension, preeclampsia, and eclampsia, are associated with cognitive decline later in life among U.S. Hispanic/Latina individuals.
-
High-Dose Buprenorphine Initiation in the Management of Opioid Use Disorder in Pregnancy. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-04 Marissa Berry, Miranda K Kiefer, Katherine A Hinely, Heather Bowden, Audra Jordan, Michael Vilensky, Kara M Rood
Buprenorphine is commonly used as a treatment for opioid use disorder (OUD). Transition to buprenorphine traditionally has been done using a low-dose initiation regimen due to concerns surrounding precipitated withdrawal. There are increasing data supporting use of a high-dose initiation regimen in the nonpregnant population. This retrospective case series describes six individuals with OUD who underwent
-
Investigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-03-31 Fong Lien Kwong, Caroline Kristunas, Clare Davenport, Ridhi Aggarwal, Jon Deeks, Sue Mallett, Sean Kehoe, Dirk Timmerman, Tom Bourne, Hilary Stobart, Richard Neal, Usha Menon, Alex Gentry-Maharaj, Lauren Sturdy, Ryan Ottridge, Sudha Sundar
To investigate psychological correlates in women referred with suspected ovarian cancer via the fast-track pathway, explore how anxiety and distress levels change at 12 months post-testing, and report cancer conversion rates by age and referral pathway.
-
Biomarker Prediction of Preeclampsia With Severe Features. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-04-03
This Clinical Practice Update provides guidance for the use of a biomarker immunoassay to aid in the risk assessment of certain pregnant women hospitalized for hypertensive disorders for the progression to preeclampsia with severe features. This document updates Practice Bulletin No. 222, Gestational Hypertension and Preeclampsia(Obstet Gynecol 2020;135:e237-60).
-
Effect of postthaw change in embryo score on single euploid embryo transfer success rates Fertil. Steril. (IF 6.7) Pub Date : 2024-04-03 Keri Bergin M.D., William Borenzweig M.D., Sarah Roger M.D., Richard Slifkin M.S., Morgan Baird M.P.H., Joseph Lee B.A., Alan B. Copperman M.D., Erkan Buyuk M.D.
To assess whether the change in embryo morphology from precryopreservation to postthaw is associated with the embryo transfer success rates in single euploid embryo transfer cycles. Retrospective cohort study. Academic affiliated fertility clinic. Patients who underwent a single euploid embryo transfer cycle from September 2016 to April 2022 were included. A decision support tool was used to assign
-
Demographic and pregnancy‐related predictors of postnatal contraception uptake: A cross‐sectional study BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-03 Malcolm Moffat, Robyn Jackowich, Christine Möller‐Christensen, Claire Sullivan, Judith Rankin
ObjectiveTo examine the uptake of postnatal contraception (PNC) and experiences of PNC care across a geographical region of England.DesignCross‐sectional online survey.SettingThe North East and North Cumbria Integrated Care System (ICS).PopulationWomen who had completed a pregnancy in the previous 3 years.MethodsThe uptake of PNC by accessed method(s) and the availability of preferred method(s) is
-
Clinical and translational research: Epidemiology to biomarker development to bedside BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-01 Robert M. Silver
In this issue of BJOG, many different types of studies and approaches were used to answer important clinical questions. These range from case–control and cohort epidemiologic studies, animal models, systematic reviews, and randomized clinical trials. There is also a focus on novelty and innovation. One of the most original studies is the use of umbilical cord mesenchymal stromal cells as a patch to
-
An evaluation of sexual function and health-related quality of life following laparoscopic surgery in individuals living with endometriosis Hum. Reprod. (IF 6.1) Pub Date : 2024-04-02 Leesa Van Niekerk, Shaunagh Pugh, Antonina Mikocka-Walus, Cecilia Ng, Rebecca O’Hara, Mike Armour, Mathew Leonardi, Subhadra Evans
STUDY QUESTION What is the relationship between sexual function, health-related quality of life (HRQoL), and laparoscopic surgery in individuals living with endometriosis? SUMMARY ANSWER A higher number of laparoscopic surgeries is significantly associated with poorer HRQoL and greater levels of sexual dysfunction in individuals with endometriosis. WHAT IS KNOWN ALREADY Prior research indicates that
-
Author reply BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-02 David Wright, Alan Wright, Laura A. Magee, Peter Von Dadelszen, Kypros H. Nicolaides
-
Uterine isthmus contractions during pregnancy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-01 Onur Yavuz MD, İbrahim Karaca MD
-
Uterine isthmus contractions: real-time ultrasound Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-01 Alba Farràs MD PhD, Nerea Maiz MD PhD, Elena Carreras MD PhD
-
Massive waste in obstetric prediction research BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-01 Jack Wilkinson
CONFLICT OF INTEREST STATEMENT JW has nothing to declare.
-
Incidence, predictors and immediate neonatal outcomes of birth asphyxia in Nigeria BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-01 Joseph Ifeanyichukwu Ikechebelu, George Uchenna Eleje, Chinyere Ukamaka Onubogu, Nnabuike Okechukwu Ojiegbe, Uchenna Ekwochi, Ifeanyichukwu Uzoma Ezebialu, Eziamaka Pauline Ezenkwele, Emily Akuabia Nzeribe, Uchenna Anthony Umeh, Ijeoma Obumneme‐Anyim, Linda Nneka Nwokeji‐Onwe, Eugenia Settecase, Innocent Anayochukwu Ugwu, Ogochukwu Chianakwana, Nkechi Theresa Ibekwe, Onyebuchi Ignatius Ezeaku, Gloria
ObjectiveTo determine the incidence and sociodemographic and clinical risk factors associated with birth asphyxia and the immediate neonatal outcomes of birth asphyxia in Nigeria.DesignSecondary analysis of data from the Maternal and Perinatal Database for Quality, Equity and Dignity Programme.SettingFifty‐four consenting referral‐level hospitals (48 public and six private) across the six geopolitical
-
Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-04-01 Anna J. M. van de Sande, Romy van Baars, Margot M. Koeneman, Cornelis G. Gerestein, Arnold‐Jan Kruse, Edith M. G. van Esch, Peggy J. de Vos van Steenwijk, Caroline L. P. Muntinga, Sten P. Willemsen, Helena C. van Doorn, Folkert J. van Kemenade, Helene J. van Beekhuizen
ObjectiveTo investigate the efficacy of imiquimod in women with residual or recurrent cervical intraepithelial neoplasia (rrCIN), compared with large loop excision of the transformation zone (LLETZ).DesignRandomised controlled non‐inferiority trial.SettingOne academic and one regional hospital in the Netherlands.PopulationThirty‐five women with rrCIN were included in the study between May 2016 and
-
Giant nabothian cysts mimicking genitourinary fistula Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-29 Daniel Lieberman MD, Catherine Seaman MD, Anna Romanova MD, Emile Gleeson MD, Lisa Dabney MD
-
Cervical atresia and an obliterated upper vagina presenting as primary amenorrhea Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-29 Rebecca J. Meiser MD, Toni S. Horton DO, Aakriti R. Carrubba MD, Sharif A. El Nashar MB BCh MS, Anita H. Chen MD
-
Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-29 Alyssa Larish, Margaret E Long
Perinatal care provides important health care opportunities for many individuals at risk for cervical cancer. Pregnancy does not alter cervical cancer screening regimens. ASCCP risk-based management has a colposcopy threshold of a 4% immediate risk of cervical intraepithelial neoplasia (CIN) 3 or cancer, but the actual risk can be considerably higher based on current and past screening results. Improving
-
Editorial: Ex vivo onco-testis microdissection Fertil. Steril. (IF 6.7) Pub Date : 2024-03-29 Stanton Charles Honig M.D.
-
Three-dimensional follicle measurements: coming soon to a clinic near you? Fertil. Steril. (IF 6.7) Pub Date : 2024-03-29 Jennifer Hirshfeld-Cytron M.D. M.S.C.I.
-
Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-28 Susanna D Mitro, Fei Xu, Catherine Lee, Eve Zaritsky, L Elaine Waetjen, Lauren A Wise, Monique M Hedderson
To compare long-term risk of reintervention across four uterus-preserving surgical treatments for leiomyomas and to assess effect modification by sociodemographic factors in a prospective cohort study in an integrated health care delivery system.
-
Active Compared With Passive Voiding Trials After Midurethral Sling Surgery: A Systematic Review. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-28 Siri Drangsholt, Cassidy Lleras, Rebecca Kindler, Maytal Babajanian, Bracha Pollack, Aleksandr Harutyunyan, Matan Grunfeld, Yehuda Gejerman, Katherine Kilkenny, Moshe Bulmash, Rahim Hirani, Parissa Alerasool, Christopher McNeil, Patrick Popiel, Elizabeth D Drugge, Cara Grimes
To compare active with passive voiding trials on the rate of passing a trial of void and discharge rates with catheter in women who have undergone midurethral sling for treatment of stress urinary incontinence (SUI).
-
Equitable Artificial Intelligence in Obstetrics, Maternal-Fetal Medicine, and Neonatology. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-28 Ryan M McAdams, Tiffany L Green
Artificial intelligence (AI) offers potential benefits in the interconnected fields of obstetrics, maternal-fetal medicine, and neonatology to bridge disciplinary silos for a unified approach. Artificial intelligence has the capacity to improve diagnostic accuracy and clinical decision making for the birthing parent-neonate dyad. There is an inherent risk of ingrained biases in AI that perpetuate existing
-
Obstetric Racial Disparities in the Era of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial and the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet. Gynecol. (IF 7.2) Pub Date : 2024-03-28 Sarahn M Wheeler, Tracy Truong, Shakthi Unnithan, Hwanhee Hong, Evan Myers, Geeta K Swamy
To evaluate the influence of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) trial and the coronavirus disease 2019 (COVID-19) pandemic on racial and ethnic differences in labor induction, pregnancy-associated hypertension, and cesarean delivery among non-Hispanic Black and non-Hispanic White low-risk, first-time pregnancies.
-
New neovagina-creating technique on the basis of a fasciocutaneous flap for Müllerian agenesis Fertil. Steril. (IF 6.7) Pub Date : 2024-03-28 Stefano Uccella M.D. Ph.D., Liliana Galli M.D., Enrico Vigato M.D., Chiara D’Alessio M.D., Rossana Di Paola M.D., Simone Garzon M.D., Alfredo Ercoli M.D. Ph.D.
Müllerian agenesis, known as Mayer-Rokitansky-Küster-Hauser syndrome, is characterized by the absence of the uterus, cervix, and two thirds of the proximal vagina. To allow sexual intercourse, dilatator-based conservative approaches and Vecchietti vaginoplasty generate progressive traction on the vaginal stump until adequate vaginal size is achieved. Other approaches create the neovagina using mucous/cutaneous
-
The association between postpartum depressive symptoms and contraception Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-27 Chloe N. Matovina MD MA, Allie Sakowicz MD MS, Emma C. Allen BS, Mayán I. Alvarado-Goldberg, Danielle Millan BA, Emily S. Miller MD MPH
Postpartum depression affects 10% to 20% of birthing people and is associated with changes in healthcare use. Little is known about the association between postpartum depressive symptoms and choice to use contraception; however, both untreated or undertreated depression and short interpregnancy intervals pose substantial perinatal health risks. This study aimed to evaluate whether postpartum depressive
-
Contribution of fetal blood sampling to determining the prognosis of congenital cytomegalovirus infections: a case-cohort study in Switzerland Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Léo Pomar PhD, Agathe Contier MSc, Milos Stojanov PhD, Cécile Guenot MD, Joanna Sichitiu MD, Anita C. Truttmann MD, Yvan Vial MD, David Baud MD PhD
Cytomegalovirus is responsible for the most common congenital infection, affecting 0.5% to 1.0% of live births in Europe. Congenital cytomegalovirus infection can be diagnosed during pregnancy by viral DNA amplification in the amniotic fluid, but the prognosis of fetuses without severe brain abnormalities remains difficult to establish on the basis of prenatal imaging alone. To identify predictors
-
Prediction of metabolic syndrome following a first pregnancy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Tetsuya Kawakita MD MS, Philip Greenland MD, Victoria L. Pemberton RNC MS CCRC, William A. Grobman MD MBA, Robert M. Silver MD, C. Noel Bairey Merz MD, Rebecca B. McNeil PhD, David M. Haas MD MS, Uma M. Reddy MD MPH, Hyagriv Simhan MD, George R. Saade MD
The prevalence of metabolic syndrome is rapidly increasing in the United States. We hypothesized that prediction models using data obtained during pregnancy can accurately predict the future development of metabolic syndrome. This study aimed to develop machine learning models to predict the development of metabolic syndrome using factors ascertained in nulliparous pregnant individuals. This was a
-
Duration of biophysical profile in periviable and very preterm low-risk pregnancies Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Luis M. Gomez MD MScE, Laura Willingham MD, Jenny Wang MD, Sebastian Nasrallah MD, Michael B. Vandillen MD, Giancarlo Mari MD MBA
In recent years, perinatal viability has shifted from 24 to 22 weeks of gestation at many institutions after improvements in survival in neonates delivered at the limit of viability. Monitoring these fetuses is essential because antenatal interventions with resuscitation efforts are available for patients at risk of delivery at the limit of viability. However, fetal monitoring using biophysical profiles
-
Enduring safety concerns for out-of-hospital births in the United States Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Amos Grünebaum MD, Frank A. Chervenak MD
-
Cefazolin as the mainstay for antibiotic prophylaxis in patients with a penicillin allergy in obstetrics and gynecology Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Karley J. Dutra MD, Gweneth B. Lazenby MD MSCR, Oluwatosin Goje MD MSCR, David E. Soper MD
Cefazolin is the most common antibiotic used for prophylaxis in obstetrics and gynecology. Among those with a penicillin allergy, alternative antibiotics are often chosen for prophylaxis, given fears of cross-reactivity between penicillin and cefazolin. Alternative antibiotics in this setting are associated with adverse sequelae, including surgical site infection, induction of bacterial resistance
-
Prevalence and prenatal diagnosis of congenital eye anomalies: A population‐based study BJOG An Int. J. Obstet. Gynaecol. (IF 5.8) Pub Date : 2024-03-26 Corentin Maillet, Lucie Guilbaud, Isabelle Monier, Babak Khoshnood, Emmanuel Bui Quoc, Anais Dugas, Nathalie Lelong, Jean‐Marie Jouannic
ObjectiveTo estimate the prevalence and trend of congenital eye anomalies (CEAs) and the rate of prenatal diagnosis over a 10‐year period.DesignRetrospective population‐based registry study.SettingAll maternity units in Paris, France, from 2010 to 2020.PopulationA cohort of 115 cases of CEA detected among all live births or stillbirths, after 22 weeks of gestation, and terminations of pregnancy.MethodsThe
-
Intracytoplasmic sperm injection revisited: ideal intervention or purveyor of disease? Fertil. Steril. (IF 6.7) Pub Date : 2024-03-25 Peter N. Schlegel M.D.